OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Copyright	115
Contents	67
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	51
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	41
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	34
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	33
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	24
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	19
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases	18
Copyright	17
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	17
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	17
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	15
Forthcoming Issues	15
COPA Syndrome from Diagnosis to Treatment	14
Artificial Intelligence in Musculoskeletal Imaging	13
The Short and Long of COVID-19	13
Lessons Learned from the COVID-19 Pandemic in Rheumatology	13
Taxonomy of Quality of Care Indicators	12
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	11
Copyright	11
Contributors	11
Imaging Challenges and Developments in Large-vessel Vasculitis	11
Contributors	10

Contents	10
Pulmonary Hypertension Associated with Connective Tissue Disease	10
Primary Cardiac Involvement in Systemic Sclerosis	9
Copyright	9
De novo Connective Tissue Disorders as Immune-related Adverse Events	9
Expanding the Treatment Team	9
Newer Immunosuppressants for Rheumatologic Disease	8
Charles L Christian	8
Daniel J McCarty, MD: A Giant of Rheumatology	8
COVID-19 and Rheumatology	8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	8
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Transforming Rheumatology Practice	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Scleroderma: Best Approaches to Patient Care	7
Cardiac MRI in Rheumatic Disease	7
Preventative Care in Scleroderma	7
E Carwile LeRoy, MD	6
Heart Failure in Rheumatic Disease	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Copyright	6
Contents	6
Sustainable Health Care and Advocacy for Rheumatologists	6
Contributors	6
Guideline Development and Implementation in Rheumatic Disease	5
Imaging of the Major Salivary Glands in Rheumatic Disease	5
Forthcoming Issues	5
Global Rheumatology	5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	5
Contributors	5
A Guide to Contemporary Clinical Practice Guidelines	5
The Challenges of New Biologic Therapies in Pediatrics	5
Imaging of Pulmonary Manifestations of Connective Tissue Disease	5
Copyright	5
Beyond Coronary Artery Disease	4
Myositis	4
Copyright	4
Contents	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Imaging in Inflammatory Bowel Disease	3
Contents	3
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	3
Dual-Energy Computed Tomography Applications in Rheumatology	3
The Role of Psychology in Pediatric Rheumatic Diseases	3

Health Care Utilization	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	3
Genetic Defects in Early-Onset Inflammatory Bowel Disease	3
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	3
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	3
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	3
Impact of Climate Change on Rheumatology Care	3
Treatment Guidelines in Gout	3
SARS-CoV-2 Infection and COVID-19 in Children	3
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	3
Expanding IPEX: Inborn Errors of Regulatory T Cells	3